Last updated: March 7, 2024
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hemorrhage
Gastric Ulcers
Gastrointestinal Diseases And Disorders
Treatment
N/AClinical Study ID
NCT06088537
23-PP-05
Ages 1-28 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All newborns ≤ 28 days corrected age or ≤ 44 amenorrhea weeks corrected agehospitalized in neonatal medicine with isolated rectorrhagia;
- Affiliated to social security ;
- Presenting isolated rectorrhagia defined as rectorrhagia without hematemesis/ repeatedvomiting/ tense or distended abdomen/ apathy/ apnea/ bradycardia or signs of severity (tachycardia, desaturation, poor coloration);
- After obtaining the biological mother's non-objection;
Exclusion
Exclusion Criteria:
- All newborns with ulcerative enterocolitis, congenital digestive malformations orrectorrhagia following digestive surgery;
- Opposition to participation in research involving the human person.
Study Design
Total Participants: 40
Study Start date:
January 24, 2024
Estimated Completion Date:
January 24, 2027
Study Description
Connect with a study center
CHU Nice - Hôpital Archet 2
Nice, Alpes-Mritimes 06000
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.